Eburicol, lichesterol, ergosterol, and obtusifoliol from polyene antibiotic-resistant mutants of Candida albicans. 1977

R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe

Two classes of polyene-resistant mutants were isolated from survivors of N-methyl-N'-nitro-N-nitrosoguanidine treatment of a wild-type Candida albicans. An analysis of the major sterols of one class revealed an accumulation of lichesterol and fecosterol while the other class accumulated eburicol, obtusifoliol, and lanosterol with minor quantities of C28 sterols.

UI MeSH Term Description Entries
D007810 Lanosterol A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS. Kryptosterol,4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009761 Nystatin Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin
D010840 Phytosterols A class of organic compounds known as sterols or STEROIDS derived from plants. Plant Sterols,Phytosteroid,Phytosteroids,Phytosterol,Plant Steroid,Plant Steroids,Plant Sterol,Steroid, Plant,Steroids, Plant,Sterol, Plant,Sterols, Plant
D010866 Natamycin Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. Pimaricin,Tennecetin,Myprozine,Pimafucin
D002174 Candicidin Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component. Levorin,Candeptin,Candicidin D,Candimon,Levorine,Vanobid
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002775 Cholestadienols Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004875 Ergosterol A steroid occurring in FUNGI. Irradiation with ULTRAVIOLET RAYS results in formation of ERGOCALCIFEROL (vitamin D2). Lumisterol,Pro-Vitamin D2,Provitamin D 2,D2, Pro-Vitamin,Pro Vitamin D2

Related Publications

R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
November 1972, Journal of general microbiology,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
February 1978, Canadian journal of biochemistry,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
January 1991, Mycoses,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
August 2004, Medical mycology,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
April 1974, Microbios,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
January 1987, Critical reviews in microbiology,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
January 1979, Microbios,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
June 1982, The Journal of antibiotics,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
October 1979, Antibiotiki,
R E Subden, and L Safe, and D C Morris, and R G Brown, and S Safe
July 1977, Biokhimiia (Moscow, Russia),
Copied contents to your clipboard!